A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Clinical trial NCT02215330 · UNKNOWN
Trial details
- NCT number
- NCT02215330
- Sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.